Showing 2921-2930 of 3117 results for "".
- PreCision Dermatology Adds to Board of Directorshttps://practicaldermatology.com/news/20121211-precision_dermatology_adds_to_board_of_directors/2459660/PreCision Dermatology, Inc. appointed Garen Bohlin to its Board of Directors, effective immediately. Mr. Bohlin has held senior executive posts in leading biotechnology companies for the past 27 years. Most recently, as the Executive Vice Pr
- ARTAS System Adopted by Minneapolis Surgeonhttps://practicaldermatology.com/news/20121204-artas_system_adopted_by_minneapolis_surgeon/2459664/Restoration Robotics, Inc. announced the first use of its revolutionary ARTAS System in Minneapolis by Dr. Ron Shapiro of Shapiro Medical Group. The ARTAS System is the first and only FDA-cleared, physician-controlled, computer-assisted technolo
- Valeant Receives FTC Clearance For Medicis Acquisitionhttps://practicaldermatology.com/news/20121121-valeant_receives_ftc_clearance_for_medicis_acquisition/2459676/The US Federal Trade Commission (FTC) granted early termination of the waiting period surrounding the proposed acquisition of Medicis Pharmaceutical Corporation by Valeant Pharmaceuticals International, Inc., effective November 15, 2012. The propo
- Picato Approved in European Unionhttps://practicaldermatology.com/news/20121119-picato_approved_in_european_union/2459677/The European Commission has granted marketing authorization for LEO Pharma's Picato (ingenol mebutate) gel for the treatment of actinic keratosis in the European Union (EU). Picato was approved in the US earlier this year.
- Xeljanz Approved for Rheumatoid Arthritishttps://practicaldermatology.com/news/20121118-xeljanz_approved_for_rheumatoid_arthritis/2459679/The FDA recently approved Xeljanz (tofacitinib) for the treatment of moderately to severely active rheumatoid arthritis (RA) in adults who have had an inadequate response to, or who are intolerant of, methotrexate. The decision comes ahead of the product's prescription drug user fee goal date of Nov
- Dermatologist Launches Rx Rebates, LLChttps://practicaldermatology.com/news/20121029-dermatologist_launches_rx_rebates_llc/2459690/Joel Bain Herron, MD, a dermatologist with Northeast Dermatology & Cosmetic Surgery Center, LLC in Gahanna, OH, founded Rx Rebates, LLC, a technology company. The website Rx_Rebates.com will be a mobile accessible site with a searchable database of digital versions of branded prescription rebate car
- Health-Conscious Women 60% More Likely to Prefer Expensive Brand-Name Drugshttps://practicaldermatology.com/news/20121025-health-conscious_women_60_more_likely_to_prefer_expensive_brand-name_drugs/2459691/The consumer market research firm Scarborough analyzed "Health-Conscious Women," defined by Scarborough as American adult women who agree that they go to the doctor regularly for checkups, generally feel they eat right, and follow a regular exercise routine. Health-Conscious Women make up 16 percent
- Medical Entrepreneur Symposium Adds Breakout Sessionhttps://practicaldermatology.com/news/20121024-medical_entrepreneur_symposium_adds_breakout_session/2459693/The Medical Entrepreneur Symposium, a unique educational meeting for physicians, their office managers, and executives in healthcare, has added a breakout session for physician entrepreneurs wanting to take great business ideas or medical devices to market. Dr. Arlen Meyers will be the course direct
- ASDS Election Results Announcedhttps://practicaldermatology.com/news/20121023-asds_election_results_announced/2459696/The ASDS has elected new officers and members of its Board of Directors whose terms began at the recent annual meeting in Atlanta. Dr. George Hruza, Clinical Professor of Dermatology and Otolaryngology at St. Louis University, was elected Vice President and will ascend to President-Elect in 2013-14
- Actress Cynthia Nixon Helps Americans to Come Face to Face with Rosaceahttps://practicaldermatology.com/news/20121014-actress_cynthia_nixon_wants_americans_to_come_face_to_face_with_rosacea/2459707/Some of the 16 million Americans affected by rosacea are not seeking therapy, but a new initiative encourages them to come "Face to Face" with the disease. Supported by Galderma in association with the National Rosacea Society